Isis Pharma (ISIS) Earns $18M Milestone from ISIS-TTRRx Development Collaboration (GSK)
Tweet Send to a Friend
Isis Pharma (Nasdaq: ISIS) has earned an $18 million milestone payment from GlaxoSmithKline (NYSE: GSK) related to the advancement of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
